Delivery Order SPE2DB25D3012-SPE2DB25FWXZU

Award Date 6/13/25
Potential Completion Date 6/16/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,404.98 firm-fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication, with a ceiling value of $17,466.01 and a period of performance through March 31, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a medication, with a ceiling value of $7,693.04 and a period of performance ending on May 28, 2025. The contract is not set aside and is a standalone award, not part of a larger vehicle. Amerisourcebergen Drug Corporation is a...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 15 MG TABLET, a medication used to treat various conditions. The total ceiling value of the contract is $6,270.42, and the ultimate completion date is June 13, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a prescription medication, with a ceiling value of $103,386.06 and an ultimate completion date of November 8, 2024. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG TABLET. The contract has a ceiling value of $12,069.11 and a completion date of August 26, 2024. It is a firm fixed-price delivery order contract type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, will be providing the requested pharmaceutical product to support federal healthcare programs and military treatment facilities. This contract...
This federal contract award is for a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication, with a ceiling value of $12,592.93 and a completion date of December 17, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RINVOQ ER 15 MG TABLET, a medication, with a firm fixed price of $15,717.70 and a period of performance through May 13, 2025. The contract is not set aside and was awarded as part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,104.84 firm fixed-price contract is for the supply of RINVOQ ER 30 MG TABLET, a prescription medication. The contract has an ultimate completion date of November 25, 2024. This contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a $50,563.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RINVOQ ER 15 MG TABLET, a medication used to treat various medical conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB25D3012
    Indefinite Delivery Contract
  • SPE2DB25D3012-SPE2DB25FWXZU
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 15 MG TABLET, a medication, with a ceiling value of $16,900.02 and a period of performance through June 16, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM) and has an extensive history of providing pharmaceutical and medical products to federal agencies, particularly the military healthcare system, through various indefinite delivery contracts.

Generated 9/12/25, 10:55 AM